Related Experiment Videos
When to Start Oral Anticoagulant Therapy Post-Stroke: From Common to Rare Conundrums
Hrvoje Budinčević1,2,3, Petra Črnac4, Andrija Meštrović4
1Department of Neurology, Sveti Duh University Hospital, Sveti Duh 64, Zagreb, 10000, Croatia. hbudincevic@gmail.com.
Purpose Of Review:
This review summarizes recent evidence on when to start oral anticoagulant therapy following stroke, including both common and rare clinical conundrums.
Recent Findings:
While previous recommendations based on Diener's rule suggested waiting up to 12 days based on stroke severity and neuroradiological findings, newer data support earlier initiation or resumption of anticoagulation, particularly for mild and moderate ischemic strokes, generally within 4 days. In patients with a history of intracerebral hemorrhage, anticoagulation resumption involves weighing thromboembolic risk against recurrent hemorrhage risk, requiring individualized decisions regarding whether and when anticoagulation should be resumed. Clinical recommendations for post-stroke anticoagulation emphasize early, individualized initiation of direct oral anticoagulants for mild-to-moderate ischemic strokes based on neuroimaging. After intracerebral hemorrhage, anticoagulation is generally restarted within 4 to 8 weeks for atrial fibrillation, with earlier resumption potentially warranted in selected high-thromboembolic-risk patients, particularly those with mechanical heart valves.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Hemorrhagic Stroke ll: Pathophysiology